SEC Form 4 · accession 0001127602-18-023816
Cibus, Inc. · CBUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel F Voytas
Officer — Chief Science Officer
Period of report
Jul 20, 2018
Accepted (ET)
Jul 24, 2018 · 8:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001705843
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 20, 2018 | M | 4,666 | $3.59 | A | 97,648 | D | |
| Common StockF1 | Jul 20, 2018 | S | 4,666 | $17.94 | D | 92,982 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $3.59 | Jul 20, 2018 | M | 4,666 | D | — | Apr 7, 2026 | Common Stock | 4,666 | 221,670 | D |
Explanation of responses
- F1Includes 100,521 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.
- F2The Stock Option was granted on April 7, 2016 and vests 20% on the grant date and 10% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter).